TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Unimedic Pharma Holding AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 | 
| Turnover | 2,749 | 3,777 | 3,628 | 
| Financial expenses | 4,394 | 1,606 | 1,303 | 
| Earnings before taxes | -4,499 | -2,964 | -1,780 | 
| EBITDA | -554 | -1,469 | -511 | 
| Total assets | 82,435 | 76,849 | 74,290 | 
| Current assets | 353 | 2,955 | 1,134 | 
| Current liabilities | 6,127 | 7,181 | 12,153 | 
| Equity capital | 764 | 301 | 487 | 
| - share capital | 304 | 284 | 293 | 
| Employees (average) | 0   | 0   | 0 | 
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Solvency | 0.9% | 0.4% | 0.7% | 
| Turnover per employee | |||
| Profit as a percentage of turnover | -163.7% | -78.5% | -49.1% | 
| Return on assets (ROA) | -0.1% | -1.8% | -0.6% | 
| Current ratio | 5.8% | 41.2% | 9.3% | 
| Return on equity (ROE) | -588.9% | -984.7% | -365.5% | 
| Change turnover | -1,296 | 258 | 866 | 
| Change turnover % | -32% | 7% | 31% | 
| Chg. No. of employees | 0   | 0 | -3 | 
| Chg. No. of employees % | -100% | 
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Total value of public sale | 0   | 0   | 0 | 
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.
 
         
                    